Open access
Aug 2026
Live Attenuated Influenza Vaccine (LAIV) for Children for the Prevention of Influenza Illness in Sweden: A Cost-Effectiveness Analysis.
In Sweden, the implementation of LAIV is estimated to be cost-effective in 2-17-year-olds by reducing disease burden and healthcare costs in both children and the broader population.
P. Brodin, F. Wilczyński, Luca Ricci-Pacifici et al.
· Infectious Disease and Thera... · 0 citations